Cargando…

Effects of Combination Therapy of Alendronate and Hormonal Therapy on Bone Mineral Density in Postmenopausal Korean Women: Multicenter, Randomized Controlled Clinical Trial

This study evaluated the effects of combination treatment with alendronate (ALEN) and hormone therapy (HT) on bone mineral density (BMD) in postmenopausal Korean women. This multicenter, randomized, controlled clinical trial enrolled 344 postmenopausal women with low BMD. The women received HT (0.62...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Byung-Koo, Lee, Dong-Yun, Park, Man Chul, Cho, Soo Hyun, Park, Hyoung Moo, Choi, Young Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426241/ https://www.ncbi.nlm.nih.gov/pubmed/28480658 http://dx.doi.org/10.3346/jkms.2017.32.6.992

Ejemplares similares

Effect of Transdermal Estrogen Therapy on Bone Mineral Density in Postmenopausal Korean Women
por: Kim, Hyo Jeong, et al.
Publicado: (2014)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Effects of Hormone Therapy on Serum Lipid Levels in Postmenopausal Korean Women
por: Lee, Jee-Yeon, et al.
Publicado: (2015)

Awareness and Experience of Menopausal Symptom and Hormone Therapy in Korean Postmenopausal Women
por: Chae, Hee Dong, et al.
Publicado: (2014)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
por: Khanizadeh, Fatemeh, et al.
Publicado: (2018)

PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass
por: Zhao, Jiao, et al.
Publicado: (2021)

Relationship between bone mineral density and dietary intake of β-carotene, vitamin C, zinc and vegetables in postmenopausal Korean women: a cross-sectional study
por: Kim, Da Eun, et al.
Publicado: (2016)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
por: Catalano, Antonino, et al.
Publicado: (2021)

The Effects of Menopausal Hormone Therapy on Serum Level of C-reactive Protein in Postmenopausal Korean Women
por: Shin, Whan, et al.
Publicado: (2019)

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study
por: Grima, Daniel T, et al.
Publicado: (2010)

Association of ADIPOR1 polymorphisms with bone mineral density in postmenopausal Korean women
por: Kim, Ha Young, et al.
Publicado: (2012)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women
por: Berkhout, J, et al.
Publicado: (2016)

Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
por: Yuan, Hu, et al.
Publicado: (2023)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial
por: Yoon, Byung-Koo, et al.
Publicado: (2021)

Non-association Between Polymorphisms of the Frizzled Receptor Genes and Bone Mineral Density in Postmenopausal Korean Women
por: Kim, Jung Gu, et al.
Publicado: (2009)

Bone Mineral Density and Prevalence of Osteoporosis in Postmenopausal Korean Women with Low-Energy Distal Radius Fractures
por: Jung, Hong Jun, et al.
Publicado: (2016)

Bone Mineral Density After Transitioning From Denosumab to Alendronate
por: Kendler, David, et al.
Publicado: (2019)

Relationship between Vitamin D, Parathyroid Hormone, and Bone Mineral Density in Elderly Koreans
por: Kim, Guilsun, et al.
Publicado: (2012)

Relation between Obesity and Bone Mineral Density and Vertebral Fractures in Korean Postmenopausal Women
por: Kim, Kyong-Chol, et al.
Publicado: (2010)

Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine
por: Radwan, Asma, et al.
Publicado: (2022)

Effects of Combination Oral Contraceptives on Bone Mineral Density and Metabolism in Perimenopausal Korean Women
por: Kim, Soo Min, et al.
Publicado: (2022)

Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial
por: Kim, Kwang Joon, et al.
Publicado: (2014)

Association between Abdominal Obesity and Lumbar Bone Mineral Density According to the Postmenopausal Period in Korean Women
por: Kim, Hyun Young, et al.
Publicado: (2017)

The Ocular Benefits of Estrogen Replacement Therapy: A Population-Based Study in Postmenopausal Korean Women
por: Na, Kyung-Sun, et al.
Publicado: (2014)

The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy
por: Sewerynek, Ewa, et al.
Publicado: (2013)

Relationship between bone mineral density, its associated physiological factors, and tooth loss in postmenopausal Korean women
por: Kim, Chang-Suk, et al.
Publicado: (2015)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

The Relationship of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Bone Mineral Density in Korean Postmenopausal Women
por: Lee, San-Hui, et al.
Publicado: (2019)

The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
por: Suh, Hee-Won, et al.
Publicado: (2012)

Association between Serum Cholesterol Level and Bone Mineral Density at Lumbar Spine and Femur Neck in Postmenopausal Korean Women
por: Go, Jeong-Ho, et al.
Publicado: (2012)

Discordance in Secular Trends of Bone Mineral Density Measurements in Different Ages of Postmenopausal Women
por: Kim, Kwang Yoon, et al.
Publicado: (2023)

The Role of Menopausal Hormone Therapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis
por: Bae, Jong-Myon, et al.
Publicado: (2018)

Effects of vitamin D deficiency and daily calcium intake on bone mineral density and osteoporosis in Korean postmenopausal woman
por: Chon, Seung Joo, et al.
Publicado: (2017)

Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
por: You, Ruxu, et al.
Publicado: (2020)

Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study
por: Villagómez Vega, Alejandra, et al.
Publicado: (2023)

Association between NF-κB Signal Pathway-Related Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
por: Shen, Xiaoyi, et al.
Publicado: (2022)

Association between Levels of Serum Ferritin and Bone Mineral Density in Korean Premenopausal and Postmenopausal Women: KNHANES 2008–2010
por: Chon, Seung Joo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h1iasese8631bnq4rn6n5fjpt6